Tag Archives: 2011 BIO International Convention

From Trade Secrets Even if the total numbers of attendees at BIO is down from its peak, it’s still an incredibly large gathering of diverse people across the biotech spectrum. The exhibit hall is a good reflection of that. I can remember when the hall was just a collection of simple individual company stands – a few employees in a booth, a poster hanging behind them. But as the industry grew, the exhibitors changed; the Read More >

From PharmaTech Talk At this week’s Partnering for Global  Health Forum, sponsored by BIO and BioVentures for Global Health, in Washington, DC, a unique panel of government leaders from emerging markets discussed what it takes to do business in their countries. Among the panelists were: Argentina’s Lino Barañao, Minister of Science, Technology and Innovative Production; India’s Maharaj K. Bhan, Secretary, Department of Biotechnology; South Africa’s Bongi Gumede, Senior General Manager, Technology Innovation and Marketing, Technology Read More >

From FierceBiotech At the height of recession, biotechs were hurting for cash. Big Pharma and its deep pockets were there to cherry-pick the best science at an affordable price from small companies that had little choice but to make deals. But the balance of power has shifted in the past year. Pharma is now face-to-face with the patent cliff, and hardly a week goes by without mention of the industry’s unproductive, yet very costly, R&D Read More >

FierceBiotech is reporting live from the annual BIO International Convention in Washington, D.C., this week. Check our our BIO 2011 microsite to keep up with news, events and tweets from the show. And if you haven’t already, register now for FierceBiotech’s executive breakfast tomorrow. We’ll examine the issues facing today’s drug developers as they navigate the challenges involved in obtaining FDA approval. Read more from John’s blog (one of our official bloggers): Live from BIO: Read More >